Search Results

There are 7398 results for: content related to: Reality Television as a Model for Online Behavior: Blogging, Photo, and Video Sharing

  1. Population pharmacokinetic modelling of the changes in atazanavir plasma clearance caused by ritonavir plasma concentrations in HIV-1 infected patients

    British Journal of Clinical Pharmacology

    Volume 82, Issue 6, December 2016, Pages: 1528–1538, José Moltó, Javier A. Estévez, Cristina Miranda, Samandhy Cedeño, Bonaventura Clotet and Marta Valle

    Version of Record online : 13 SEP 2016, DOI: 10.1111/bcp.13072

  2. You have free access to this content
    Effects of ritonavir-boosted darunavir vs. ritonavir-boosted atazanavir on lipid and glucose parameters in HIV-negative, healthy volunteers

    HIV Medicine

    Volume 10, Issue 5, May 2009, Pages: 318–327, F Tomaka, E Lefebvre, V Sekar, B Van Baelen, T Vangeneugden, A Vandevoorde and G Diego Miralles

    Version of Record online : 5 FEB 2009, DOI: 10.1111/j.1468-1293.2008.00690.x

  3. Time-dependent interaction of ritonavir in chronic use: The power balance between inhibition and induction of P-glycoprotein and cytochrome P450 3A

    Journal of Pharmaceutical Sciences

    Volume 102, Issue 6, June 2013, Pages: 2044–2055, Keizo Fukushima, Shinji Kobuchi, Kazunori Mizuhara, Hiroaki Aoyama, Kanji Takada and Nobuyuki Sugioka

    Version of Record online : 15 APR 2013, DOI: 10.1002/jps.23545


    Journal of Applied Econometrics

    Volume 28, Issue 3, April/May 2013, Pages: 458–477, Michael P. Clements and Ana Beatriz Galvão

    Version of Record online : 14 MAY 2012, DOI: 10.1002/jae.2274

  5. Surface modification of carbon fiber and the mechanical properties of the silicone rubber/carbon fiber composites

    Journal of Applied Polymer Science

    Volume 126, Issue S2, 25 November 2012, Pages: E410–E418, Eung Soo Kim, Tae Hwa Lee, Eun Jeong Kim and Jin-San Yoon

    Version of Record online : 26 APR 2012, DOI: 10.1002/app.36959

  6. You have free access to this content
    Retroactive, a membrane-anchored extracellular protein related to vertebrate snake neurotoxin-like proteins, is required for cuticle organization in the larva of Drosophila melanogaster

    Developmental Dynamics

    Volume 233, Issue 3, July 2005, Pages: 1056–1063, Bernard Moussian, Johannes Söding, Heinz Schwarz and Christiane Nüsslein-Volhard

    Version of Record online : 20 APR 2005, DOI: 10.1002/dvdy.20389

  7. Effect of organic modification on structure and properties of room-temperature vulcanized silicone rubber/montmorillonite nanocomposites

    Journal of Applied Polymer Science

    Volume 129, Issue 4, 15 August 2013, Pages: 1852–1860, Wang Jincheng and Hao Wenli

    Version of Record online : 24 DEC 2012, DOI: 10.1002/app.38887

  8. You have free access to this content
    Saquinavir and ritonavir pharmacokinetics following combined ritonavir and saquinavir (soft gelatin capsules) administration

    British Journal of Clinical Pharmacology

    Volume 52, Issue 3, September 2001, Pages: 255–264, Neil Buss, Paul Snell, Jürgen Bock, Ann Hsu and Karin Jorga

    Version of Record online : 20 DEC 2001, DOI: 10.1046/j.0306-5251.2001.01452.x

  9. You have free access to this content
    The effect of ritonavir on saquinavir plasma concentration is independent of ritonavir dosage: combined analysis of pharmacokinetic data from 97 subjects

    HIV Medicine

    Volume 3, Issue 2, April 2002, Pages: 97–104, JM Kilby, 1 A Hill and 2 N Buss 3

    Version of Record online : 14 MAY 2002, DOI: 10.1046/j.1468-1293.2002.00090.x

  10. The FDA Approved HIV-1 Protease Inhibitors for Treatment of HIV/AIDS

    Standard Article

    Burger's Medicinal Chemistry and Drug Discovery

    Arun K. Ghosh, David D. Anderson and Hiroaki Mitsuya

    Published Online : 27 AUG 2010, DOI: 10.1002/0471266949.bmc224

  11. Surveillance on Reality Television and Facebook: From Authenticity to Flowing Data

    Communication Theory

    Volume 21, Issue 2, May 2011, Pages: 111–129, Rachel E. Dubrofsky

    Version of Record online : 8 APR 2011, DOI: 10.1111/j.1468-2885.2011.01378.x

  12. You have free access to this content
    The effect of low-dose ritonavir monotherapy on fasting serum lipid concentrations

    HIV Medicine

    Volume 6, Issue 6, November 2005, Pages: 421–425, SD Shafran, LD Mashinter and SE Roberts

    Version of Record online : 28 OCT 2005, DOI: 10.1111/j.1468-1293.2005.00328.x

  13. Bioavailability enhancement of a BCS IV compound via an amorphous combination product containing ritonavir

    Journal of Pharmacy and Pharmacology

    Volume 68, Issue 5, May 2016, Pages: 678–691, Dave A. Miller, Justin M. Keen, Chris Brough, Daniel J. Ellenberger, Marshall Cisneros, Robert O. Williams III and James W. McGinity

    Version of Record online : 10 OCT 2015, DOI: 10.1111/jphp.12478

  14. Effect of intercalation agent on the structure and properties of OMMT and RTV/OMMT composites

    Journal of Applied Polymer Science

    Volume 123, Issue 3, 5 February 2012, Pages: 1293–1301, Wang Jincheng, Yang Ke and Xu Nan

    Version of Record online : 15 AUG 2011, DOI: 10.1002/app.34628

  15. The Effect of Atazanavir and Atazanavir/Ritonavir on UDP-Glucuronosyltransferase Using Lamotrigine as a Phenotypic Probe

    Clinical Pharmacology & Therapeutics

    Volume 84, Issue 6, December 2008, Pages: 698–703, DM Burger, A Huisman, N Van Ewijk, H Neisingh, P Van Uden, GA Rongen, P Koopmans and RJ Bertz

    Version of Record online : 4 JUN 2008, DOI: 10.1038/clpt.2008.106

  16. You have free access to this content
    Regimen-dependent variations in adherence to therapy and virological suppression in patients initiating protease inhibitor-based highly active antiretroviral therapy

    HIV Medicine

    Volume 7, Issue 5, July 2006, Pages: 311–316, DM Moore, RS Hogg, B Yip, E Wood, M Harris and JSG Montaner

    Version of Record online : 24 MAY 2006, DOI: 10.1111/j.1468-1293.2006.00381.x

  17. You have free access to this content
    A meta-analysis of the efficacy and safety of unboosted atazanavir compared with ritonavir-boosted protease inhibitor maintenance therapy in HIV-infected adults with established virological suppression after induction

    HIV Medicine

    Volume 15, Issue 5, May 2014, Pages: 301–310, J Baril, B Conway, P Giguère, N Ferko, S Hollmann and JB Angel

    Version of Record online : 9 DEC 2013, DOI: 10.1111/hiv.12118

  18. You have free access to this content
    Pharmacokinetic and tolerability profile of twice-daily saquinavir hard gelatin capsules and saquinavir soft gelatin capsules boosted with ritonavir in healthy volunteers

    HIV Medicine

    Volume 4, Issue 2, April 2003, Pages: 94–100, M Kurowski, T Sternfeld, A Sawyer, A Hill and C Möcklinghoff

    Version of Record online : 22 APR 2003, DOI: 10.1046/j.1468-1293.2003.00143.x

  19. A hybrid design to optimize preparation of lopinavir loaded solid lipid nanoparticles and comparative pharmacokinetic evaluation with marketed lopinavir/ritonavir coformulation

    Journal of Pharmacy and Pharmacology

    Volume 66, Issue 7, July 2014, Pages: 912–926, Punna Rao Ravi, Rahul Vats, Vikas Dalal and Aditya Narasimha Murthy

    Version of Record online : 18 FEB 2014, DOI: 10.1111/jphp.12217

  20. Population Pharmacokinetics of Boosted-Elvitegravir in HIV-Infected Patients

    The Journal of Clinical Pharmacology

    Volume 56, Issue 6, June 2016, Pages: 723–732, Joseph M. Custodio, Toufigh Gordi, Lijie Zhong, Kah Hiing J. Ling and Srini Ramanathan

    Version of Record online : 21 DEC 2015, DOI: 10.1002/jcph.657